Information  X 
Enter a valid email address

Plus500 Ltd (PLUS)

  Print      Mail a friend

Monday 09 March, 2020

Plus500 Ltd

Transaction in Own Shares

RNS Number : 3559F
Plus500 Limited
09 March 2020
 

9 March 2020

Plus500 Ltd.

("Plus500" or "the Company")

 Transaction in Own Shares

Plus500, a leading online service provider for trading Contracts for Difference ("CFDs") internationally, announces that, in accordance with the terms of its share buyback programme announced on 12 February 2020 ("Share Buyback Programme"), the Company purchased the following number of its ordinary shares of ILS 0.01 each through Credit Suisse Securities (Europe) Limited .

Date of purchase:

6 March 2020

Aggregate number of ordinary shares of ILS 0.01 each purchased:

 31,500

Lowest price paid per share (GBp):

939.60

Highest price paid per share (GBp):

 953.40

Volume weighted average price paid per share (GBp):

946.26

 

The Company will hold the repurchased shares in treasury. Following the purchase of these shares, the remaining number of ordinary shares in issue will be 107,619,154 (excluding treasury shares), and the company will hold 7,269,223 ordinary shares in treasury. Therefore, the total voting rights in Plus500 will be 107,619,154. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.  

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Credit Suisse Securities (Europe) Limited as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Venue

131

941.0

8:18:52

LSE

439

944.8

8:18:54

LSE

120

939.6

8:19:30

LSE

31

944.4

8:19:32

LSE

14

944.4

8:19:32

LSE

9

944.8

8:19:54

LSE

22

944.8

8:19:54

LSE

148

942.6

8:20:14

LSE

2,104

942.0

8:20:14

LSE

2,106

942.0

8:20:14

LSE

2,106

942.0

8:20:14

LSE

406

944.2

8:20:54

LSE

64

944.2

8:20:54

LSE

55

946.0

8:21:54

LSE

62

946.2

8:22:54

LSE

71

946.2

8:22:56

LSE

130

947.8

8:23:54

LSE

136

943.2

8:24:54

LSE

2,103

943.0

8:24:54

LSE

2,103

943.0

8:24:55

LSE

2,103

943.0

8:24:55

LSE

293

946.4

8:24:55

LSE

744

948.6

8:26:55

LSE

74

948.6

8:26:55

LSE

17

948.6

8:26:55

LSE

28

948.6

8:27:01

LSE

13

948.2

8:28:55

LSE

1,160

950.8

8:29:55

LSE

77

950.8

8:29:55

LSE

541

952.6

8:29:58

LSE

152

949.2

8:33:40

LSE

142

948.0

8:34:14

LSE

93

942.4

8:34:39

LSE

191

947.4

8:35:55

LSE

341

948.0

8:36:15

LSE

39

948.4

8:37:19

LSE

399

946.8

8:37:19

LSE

598

947.0

8:37:19

LSE

272

947.0

8:37:19

LSE

478

947.0

8:37:19

LSE

2,095

947.0

8:37:20

LSE

332

947.0

8:37:20

LSE

136

947.8

8:39:13

LSE

400

949.0

8:39:26

LSE

149

948.8

8:41:10

LSE

146

947.8

8:44:23

LSE

95

952.2

8:46:15

LSE

174

948.2

8:46:27

LSE

693

949.0

8:46:27

LSE

1,069

949.0

8:46:27

LSE

556

949.0

8:46:27

LSE

235

950.8

8:48:57

LSE

180

950.0

8:49:23

LSE

42

949.4

8:49:33

LSE

137

949.4

8:49:34

LSE

3

948.6

8:53:51

LSE

191

948.6

8:53:51

LSE

182

951.4

8:59:01

LSE

167

953.4

9:18:13

LSE

650

951.8

9:18:13

LSE

1,432

952.0

9:18:13

LSE

635

951.8

9:18:13

LSE

186

952.0

9:18:13

LSE

166

951.0

9:23:06

LSE

306

950.0

9:23:13

LSE

113

947.6

9:37:45

LSE

104

949.0

9:46:33

LSE

170

948.8

9:46:33

LSE

86

949.0

9:47:15

LSE

42

949.0

9:47:53

LSE

13

949.0

9:47:53

LSE

60

951.2

10:20:04

LSE

56

951.2

10:20:04

LSE

110

950.8

10:20:04

LSE

23

950.8

10:20:04

LSE

251

951.6

10:21:14

LSE

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSBDGDXDBGDGGI

a d v e r t i s e m e n t